OVID THERAPEUTICS INC (OVID:NASDAQ)
$2.64 0.1 (3.937%)
Analysed OVID THERAPEUTICS INC (OVID:NASDAQ) News Sources
Ovid Therapeutics Announces Pricing of $60 Million Private Placement
18-03-2026
yahoo.com
Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results
18-03-2026
yahoo.com
Ovid Therapeutics (OVID) Q4 Earnings and Revenues Surpass Estimates
18-03-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Lower Ahead of Key Economic Data, FOMC Meeting
18-03-2026
yahoo.com
Here's Why Ovid Therapeutics Stock Popped Higher Today
18-03-2026
fool.com
Ovid Therapeutics Q4 Earnings Call Highlights
18-03-2026
marketbeat.com
Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14
08-04-2026
yahoo.com
Here is Why Ovid Therapeutics (OVID) is One of the Best Fast Growing Penny Stocks
10-05-2026
yahoo.com
Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
12-05-2026
yahoo.com
We're Hopeful That Ovid Therapeutics (NASDAQ:OVID) Will Use Its Cash Wisely
14-05-2026
yahoo.com
What is the current price of OVID THERAPEUTICS INC (OVID:NASDAQ)?
The current price of OVID THERAPEUTICS INC (OVID:NASDAQ) is $2.64.
OVID THERAPEUTICS INC (OVID:NASDAQ) absolute price change since previous trading day?
The absolute price change of OVID THERAPEUTICS INC (OVID:NASDAQ) since the previous trading day is $0.1.
OVID THERAPEUTICS INC (OVID:NASDAQ) percentage price change since previous trading day?
The percentage price change of OVID THERAPEUTICS INC (OVID:NASDAQ) since the previous trading day is 3.937%.
What is the most recent average sentiment score for OVID THERAPEUTICS INC (OVID:NASDAQ)?
The most recent average sentiment score for OVID THERAPEUTICS INC (OVID:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for OVID THERAPEUTICS INC (OVID:NASDAQ)?
The most recent sentiment for OVID THERAPEUTICS INC (OVID:NASDAQ) is .
SEC-8K** Filing Available For OVID THERAPEUTICS INC (OVID:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.